Determinants of lymphoid-myeloid lineage diversification

Annual Review of Immunology

Volumn 24, Issue , 2006, Pages 705-738

  Laiosa, Catherine V ^a   Stadtfeld, Matthias ^a   Graf, Thomas ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Hematopoietic lineage trees; Hematopoietic stem cell; Lineage commitment; Lineage priming; Transcription factors

Indexed keywords

CYTOKINE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR PU 1;

B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL MATURATION; CELL REPROGRAMMING; CHROMATIN; DENDRITIC CELL; ERYTHROID CELL; GENE EXPRESSION; GRANULOCYTE; HEMATOPOIESIS; HEMATOPOIETIC LINEAGE TREE; HEMATOPOIETIC STEM CELL; HUMAN; LINEAGE COMMITMENT; LINEAGE PRIMING; LYMPHOID CELL; MACROPHAGE; MEGAKARYOCYTE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROLYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE STEM CELL;

ANIMALS; B-LYMPHOCYTES; CELL DIFFERENTIATION; DENDRITIC CELLS; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEMATOPOIETIC STEM CELLS; HUMANS; KILLER CELLS, NATURAL; LIVER; LYMPHOPOIESIS; MICE; MODELS, IMMUNOLOGICAL; MYELOPOIESIS; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 33644641356     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.24.021605.090742     Document Type: Review

References (206)

1. Rothenberg EV, Anderson MK. 2002. Elements of transcription factor network design for T-lineage specification. Dev. Biol. 246:29-44
2. Singh H, Medina KL, Pongubala JM. 2005. Contingent gene regulatory networks and B cell fate specification. Proc. Natl. Acad. Sci. USA 102:4949-53
3. Graf T. 2002. Differentiation plasticity of hematopoietic cells. Blood 99:3089-101
4. Orkin SH. 2000. Diversification of haematopoietic stem cells to specific lineages. Nat. Rev. Genet. 1:57-64
5. Ogawa M. 1993. Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844-53
6. Morrison SJ, Hemmati HD, Wandycz AM, Weissman IL. 1995. The purification and characterization of fetal liver hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 92:10302-6
7. Morrison SJ, Weissman IL. 1994. The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. Immunity 1:661-73
8. Spangrude GJ, Heimfeld S, Weissman IL. 1988. Purification and characterization of mouse hematopoietic stem cells. Science 241:58-62
9. Christensen JL, Weissman IL. 2001. Flk-2 is a marker in hematopoietic stem cell differentiation: a simple method to isolate long-term stem cells. Proc. Natl. Acad. Sci. USA 98:14541-46
10. Kiel MJ, Yilmaz OH, Iwashita T, Terhorst C, Morrison SJ. 2005. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell 121:1109-21
11. - short-term hematopoietic stem cells capable of rapidly reconstituting and rescuing myeloablated transplant recipients. Blood 105:2717-23
12. Osawa M, Hanada K, Hamada H, Nakauchi H. 1996. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273:242-45
13. Kondo M, Weissman IL, Akashi K. 1997. Identification of clonogenic common lymphoid progenitors in mouse bone marrow. Cell 91:661-72
14. Akashi K, Traver D, Miyamoto T, Weissman IL. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193-97
15. Denburg JA, Telizyn S, Messner H, Lim B, Jamal N, et al. 1985. Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. Blood 66:312-18
16. Iwasaki H, Mizuno S, Mayfield R, Shigematsu H, Arinobu Y, et al. 2005. Identification of eosinophil lineage-committed progenitors in the murine bone marrow. J. Exp. Med. 201:1891-97
17. + lympho-myeloid stem cells lacking erythro-megakaryocytic potential a revised road map for adult blood lineage commitment. Cell 121:295-306
18. Anderson MK, Pant R, Miracle AL, Sun X, Luer CA, et al. 2004. Evolutionary origins of lymphocytes: ensembles of T cell and B cell transcriptional regulators in a cartilaginous fish. J. Immunol. 172:5851-60
19. Kondo M, Scherer DC, Miyamoto T, King AG, Akashi K, et al. 2000. Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines. Nature 407:383-86
20. + lymphoid-restricted bone marrow cells with T precursor potential. Nat. Immunol. 4:866-73
21. Allman D, Sambandam A, Kim S, Miller JP, Pagan A, et al. 2003. Thymopoiesis independent of common lymphoid progenitors. Nat. Immunol. 4:168-74
22. Schwarz BA, Bhandoola A. 2004. Circulating hematopoietic progenitors with T lineage potential. Nat. Immunol. 5:953-60
23. Petrie HT, Kincade PW. 2005. Many roads, one destination for T cell progenitors. J. Exp. Med. 202:11-13
24. Rothenberg EV, Taghon T. 2005. Molecular genetics of T cell development. Annu. Rev. Immunol. 23:601-49
25. Shen HQ, Lu M, Ikawa T, Masuda K, Ohmura K, et al. 2003. T/NK bipotent progenitors in the thymus retain the potential to generate dendritic cells. J. Immunol. 171:3401-6
26. Benz C, Bleul CC. 2005. A multipotent precursor in the thymus maps to the branching point of the T versus B lineage decision. J. Exp. Med. 202:21-31
27. Porritt HE, Rumfelt LL, Tabrizifard S, Schmitt TM, Zuniga-Pflucker JC, Petric HT. 2004. Heterogeneity among DN1 prothymocytes reveals multiple progenitors with different capacities to generate T cell and non-T cell lineages. Immunity 20:735-45
28. Balciunaite G, Ceredig R, Rolink AG. 2005. The earliest subpopulation of mouse thymocytes contains potent T, significant macrophage, and natural killer cell but no B-lymphocyte potential. Blood 105:1930-36
29. Zediak VP, Maillard I, Bhandoola A. 2005. Closer to the source: Notch and the nature of thymus-settling cells. Immunity 23:245-48
30. Shortman K, Liu YJ. 2002. Mouse and human dendritic cell subtypes. Nat. Rev. Immunol. 2:151-61
31. Traver D, Akashi K, Manz M, Merad M, Miyamoto T, et al. 2000. Development of CD8α-positive dendritic cells from a common myeloid progenitor. Science 290:2152-54
32. Manz MG, Traver D, Miyamoto T, Weissman IL, Akashi K. 2001. Dendritic cell potentials of early lymphoid and myeloid progenitors. Blood 97:3333-41
33. Lu M, Kawamoto H, Katsube Y, Ikawa T, Katsura Y. 2002. The common myelolymphoid progenitor: a key intermediate stage in hemopoiesis generating T and B cells. J. Immunol. 169:3519-25
34. Katsura Y. 2002. Redefinition of lymphoid progenitors. Nat. Rev. Immunol. 2:127-32
35. Kawamoto H, Ikawa T, Ohmura K, Fujimoto S, Katsura Y. 2000. T cell progenitors emerge earlier than B cell progenitors in the murine fetal liver. Immunity 12:441-50
36. - cells, as well as macrophages. J. Immunol. 166:6593-601
37. Traver D, Miyamoto T, Christensen J, Iwasaki-Arai J, Akashi K, Weissman IL. 2001. Fetal liver myelopoiesis occurs through distinct, prospectively isolatable progenitor subsets. Blood 98:627-35
38. Enver T, Heyworth CM, Dexter TM. 1998. Do stem cells play dice? Blood 92:348-51
39. Metcalf D. 1998. Lineage commitment and maturation in hematopoietic cells: the case for extrinsic regulation. Blood 92:345-47
40. Lieschke GJ, Grail D, Hodgson G, Metcalf D, Stanley E, et al. 1994. Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84:1737-46
41. Wu H, Liu X, Jaenisch R, Lodish HF. 1995. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 83:59-67
42. Stanley E, Lieschke GJ, Grail D, Metcalf D, Hodgson G, et al. 1994. Granulocyte/macrophage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary pathology. Proc. Natl. Acad. Sci. USA 91:5592-96
43. Seymour JF, Lieschke GJ, Grail D, Quilici C, Hodgson G, Dunn AR. 1997. Mice lacking both granulocyte colony-stimulating factor (CSF) and granulocyte-macrophage CSF have impaired reproductive capacity, perturbed neonatal granulopoiesis, lung disease, amyloidosis, and reduced long-term survival. Blood 90:3037-49
44. Lieschke GJ, Stanley E, Grail D, Hodgson G, Sinickas V, et al. 1994. Mice lacking both macrophage- and granulocyte-macrophage colony-stimulating factor have macrophages and coexistent osteopetrosis and severe lung disease. Blood 84:27-35
45. Pharr PN, Ogawa M, Hofbauer A, Longmore GD. 1994. Expression of an activated erythropoietin or a colony-stimulating factor 1 receptor by pluripotent progenitors enhances colony formation but does not induce differentiation. Proc. Natl. Acad. Sci. USA 91:7482-86
46. McArthur GA, Rohrschneider LR, Johnson GR. 1994. Induced expression of c-fms in normal hematopoietic cells shows evidence for both conservation and lineage restriction of signal transduction in response to macrophage colony-stimulating factor. Blood 83:972-81
47. Stoffel R, Ziegler S, Ghilardi N, Ledermann B, de Sauvage FJ, Skoda RC. 1999. Permissive role of thrombopoietin and granulocyte colony-stimulating factor receptors in hematopoietic cell fate decisions in vivo. Proc. Natl. Acad. Sci. USA 96:698-702
48. Semerad CL, Poursine-Laurent J, Liu F, Link DC. 1999. A role for G-CSF receptor signaling in the regulation of hematopoietic cell function but not lineage commitment or differentiation. Immunity 11:153-61
49. Borzillo GV, Ashmun RA, Sherr CJ. 1990. Macrophage lineage switching of murine early pre-B lymphoid cells expressing transduced fms genes. Mol. Cell. Biol. 10:2703-14
50. Iwasaki-Arai J, Iwasaki H, Miyamoto T, Watanabe S, Akashi K. 2003. Enforced granulocyte/macrophage colony-stimulating factor signals do not support lymphopoiesis, but instruct lymphoid to myelomonocytic lineage conversion. J. Exp. Med. 197:1311-22
51. King AG, Kondo M, Scherer DC, Weissman IL. 2002. Lineage infidelity in myeloid cells with TCR gene rearrangement: a latent developmental potential of proT cells revealed by ectopic cytokine receptor signaling. Proc. Natl. Acad. Sci. USA 99:4508-13
52. + stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15:659-69
53. Mackarehtschian K, Hardin JD, Moore KA, Boast S, Goff SP, Lemischka IR. 1995. Targeted disruption of the flk2/flt3 gene leads to deficiencies in primitive hematopoietic progenitors. Immunity 3:147-61
54. Sitnicka E, Bryder D, Theilgaard-Monch K, Buza-Vidas N, Adolfsson J, Jacobsen SE. 2002. Key role of flt3 ligand in regulation of the common lymphoid progenitor but not in maintenance of the hematopoietic stem cell pool. Immunity 17:463-72
55. Corcoran AE, Riddell A, Krooshoop D, Venkitaraman AR. 1998. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature 391:904-7
56. Peschon JJ, Morrissey PJ, Grabstein KH, Ramsdell FJ, Maraskovsky E, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180:1955-60
57. von Freeden-Jeffry U, Solvason N, Howard M, Murray R. 1997. The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression. Immunity 7:147-54
58. Akashi K, Kondo M, von Freeden-Jeffry U, Murray R, Weissman IL. 1997. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 89:1033-41
59. Dias S, Silva H Jr, Cumano A, Vieira P. 2005. Interleukin-7 is necessary to maintain the B cell potential in common lymphoid progenitors. J. Exp. Med. 201:97179
60. 58a. Kikuchi K, Lai AY, Hsu C-L, Kondo M. 2005. IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF. J. Exp. Med. 201:1197-203
61. Sitnicka E, Brakebusch C, Martensson IL, Svensson M, Agace WW, et al. 2003. Complementary signaling through flt3 and interleukin-7 receptor α is indispensable for fetal and adult B cell genesis. J. Exp. Med. 198:1495-506
62. Matthias P, Rolink AG. 2005. Transcriptional networks in developing and mature B cells. Nat. Rev. Immunol. 5:497-508
63. Busslinger M. 2004. Transcriptional control of early B cell development. Annu. Rev. Immunol. 22:55-79
64. Maillard I, Fang T, Pear WS. 2005. Regulation of lymphoid development, differentiation, and function by the Notch pathway. Annu. Rev. Immunol. 23:945-74
65. Engel I, Murre C. 2001. The function of E- and Id proteins in lymphocyte development. Nat. Rev. Immunol. 1:193-99
66. Tenen DG. 2003. Disruption of differentiation in human cancer: AML shows the way. Nat. Rev. Cancer 3:89-101
67. Georgopoulos K, Bigby M, Wang JH, Molnar A, Wu P, et al. 1994. The Ikaros gene is required for the development of all lymphoid lineages. Cell 79:143-56
68. Wang JH, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, et al. 1996. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 5:537-49
69. McKercher SR, Torbett BE, Anderson KL, Henkel GW, Vestal DJ, et al. 1996. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:5647-58
70. Scott EW, Simon MC, Anastasi J, Singh H. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 265:1573-77
71. Georgopoulos K. 2002. Haematopoietic cell-fate decisions, chromatin regulation and Ikaros. Nat. Rev. Immunol. 2:162-74
72. Lopez RA, Schoetz S, DeAngelis K, O'Neill D, Bank A. 2002. Multiple hematopoietic defects and delayed globin switching in Ikaros null mice. Proc. Natl. Acad. Sci. USA 99:602-7
73. Nichogiannopoulou A, Trevisan M, Neben S, Friedrich C, Georgopoulos K. 1999. Defects in hemopoietic stem cell activity in Ikaros mutant mice. J. Exp. Med. 190:1201-14
74. Klug CA, Morrison SJ, Masek M, Hahm K, Smale ST, Weissman IL. 1998. Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes. Proc. Natl. Acad. Sci. USA 95:657-62
75. Morgan B, Sun L, Avitahl N, Andrikopoulos K, Ikeda T, et al. 1997. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16:2004-13
76. Georgopoulos K, Winandy S, Avitahl N. 1997. The role of the Ikaros gene in lymphocyte development and homeostasis. Annu. Rev. Immunol. 15:155-76
77. Spain LM, Guerriero A, Kunjibettu S, Scott EW. 1999. T cell development in PU.1-deficient mice. J. Immunol. 163:2681-87
78. Guerriero A, Langmuir PB, Spain LM, Scott EW. 2000. PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells. Blood 95:879-85
79. Anderson KL, Perkin H, Surh CD, Venturini S, Maki RA, Torbett BE. 2000. Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells. J. Immunol. 164:1855-61
80. Iwasaki H, Somoza C, Shigematsu H, Duprez EA, Iwasaki-Arai J, et al. 2005. Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. Blood 106:1590-600
81. Dakic A, Metcalf D, Di Rago L, Mifsud S, Wu L, Nutt SL. 2005. PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis. J. Exp. Med. 201:1487-502
82. Zhang P, Iwasaki-Arai J, Iwasaki H, Fenyus ML, Dayaram T, et al. 2004. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBPα. Immunity 21:853-63
83. DeKoter RP, Lee HJ, Singh H. 2002. PU.1 regulates expression of the interleukin-7 receptor in lymphoid progenitors. Immunity 16:297-309
84. Medina KL, Pongubala JM, Reddy KL, Lancki DW, Dekoter R, et al. 2004. Assembling a gene regulatory network for specification of the B cell fate. Dev. Cell 7:607-17
85. Lin H, Grosschedl R. 1995. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376:263-67
86. von Freeden-Jeffry U, Vieira P, Lucian LA, McNeil T, Burdach SE, Murray R. 1995. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J. Exp. Med. 181:1519-26
87. 84a. Ye M, Ermakova O, Graf T. 2005. PU.1 is not strictly required for B cell development and its absence induces a B-2 to B-1 cell switch. J. Exp. Med. 202:1411-22
88. Bain G, Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, et al. 1994. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79:885-92
89. Sun XH. 1994. Constitutive expression of the Id1 gene impairs mouse B cell development. Cell 79:893-900
90. Sigvardsson M, O'Riordan M, Grosschedl R. 1997. EBF and E47 collaborate to induce expression of the endogenous immunoglobulin surrogate light chain genes. Immunity 7:25-36
91. Gisler R, Sigvardsson M. 2002. The human V-preB promoter is a target for coordinated activation by early B cell factor and E47. J. Immunol. 168:5130-38
92. Kee BL, Rivera RR, Murre C. 2001. Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-β. Nat. Immunol. 2:242-47
93. Zhuang Y, Cheng P, Weintraub H. 1996. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol. Cell. Biol. 16:2898-905
94. O'Riordan M, Grosschedl R. 1999. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A. Immunity 11:21-31
95. Sigvardsson M, Clark DR, Fitzsimmons D, Doyle M, Akerblad P, et al. 2002. Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter. Mol. Cell. Biol. 22:8539-51
96. Urbanek P, Wang ZQ, Fetka I, Wagner EF, Busslinger M. 1994. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79:901-12
97. Nutt SL, Morrison AM, Dorfler P, Rolink A, Busslinger M. 1998. Identification of BSAP (Pax-5) target genes in early B-cell development by loss- and gain-of-function experiments. EMBO J. 17:2319-33
98. Nutt SL, Heavey B, Relink AG, Busslinger M. 1999. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 401:556-62
99. Souabni A, Cobaleda C, Schebesta M, Busslinger M. 2002. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1. Immunity 17:781-93
100. Chiang MY, Monroe JG. 1999. BSAP/Pax5A expression blocks survival and expansion of early myeloid cells implicating its involvement in maintaining commitment to the B-lymphocyte lineage. Blood 94:3621-32
101. Radtke F, Wilson A, Stark G, Bauer M, van Meerwijk J, et al. 1999. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity 10:547-58
102. Ting CN, Olson MC, Barton KP, Leiden JM. 1996. Transcription factor GATA-3 is required for development of the T-cell lineage. Nature 384:474-78
103. Hendriks RW, Nawijn MC, Engel JD, van Doorninck H, Grosveld F, Karis A. 1999. Expression of the transcription factor GATA-3 is required for the development of the earliest T cell progenitors and correlates with stages of cellular proliferation in the thymus. Eur. J. Immunol. 29:1912-18
104. Pai SY, Truitt ML, Ting CN, Leiden JM, Glimcher LH, Ho IC. 2003. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19:863-75
105. Pai SY, Truitt ML, Ho IC. 2004. GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells. Proc. Natl. Acad. Sci. USA 101:1993-98
106. Han H, Tanigaki K, Yamamoto N, Kuroda K, Yoshimoto M, et al. 2002. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 14:637-45
107. Pui JC, Allman D, Xu L, DeRocco S, Karnell FG, et al. 1999. Notch1 expression in early lymphopoiesis influences B versus T lineage determination. Immunity 11:299-308
108. Schmitt TM, Zuniga-Pflucker JC. 2002. Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro. Immunity 17:749-56
109. Schmitt TM, Ciofani M, Petrie HT, Zuniga-Pflucker JC. 2004. Maintenance of T cell specification and differentiation requires recurrent Notch receptor-ligand interactions. J. Exp. Med. 200:469-79
110. Taghon TN, David ES, Zuniga-Pflucker JC, Rothenberg EV. 2005. Delayed, asynchronous, and reversible T-lineage specification induced by Notch/Delta signaling. Genes Dev. 19:965-78
111. Tremblay M, Herblot S, Lecuyer E, Hoang T. 2003. Regulation of pTα gene expression by a dosage of E2A, HEB, and SCL. J. Biol. Chem. 278:12680-87
112. Bain G, Engel I, Robanus Maandag EC, te Riele HP, Voland JR, et al. 1997. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17:4782-91
113. Barndt R, Dai MF, Zhuang Y. 1999. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during αβ thymopoiesis. J. Immunol. 163:3331-43
114. Barndt RJ, Dai M, Zhuang Y. 2000. Functions of E2A-HEB heterodimers in T-cell development revealed by a dominant negative mutation of HEB. Mol. Cell. Biol. 20:6677-85
115. Heemskerk MH, Blom B, Nolan G, Stegmann AP, Bakker AQ, et al. 1997. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186:1597-602
116. Anderson MK, Hernandez-Hoyos G, Diamond RA, Rothenberg EV. 1999. Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage. Development 126:3131-48
117. Anderson MK, Weiss AH, Hernandez-Hoyos G, Dionne CJ, Rothenberg EV. 2002. Constitutive expression of PU.1 in fetal hematopoietic progenitors blocks T cell development at the pro-T cell stage. Immunity 16:285-96
118. Colucci F, Samson SI, DeKoter RP, Lantz O, Singh H, Di Santo JP. 2001. Differential requirement for the transcription factor PU.1 in the generation of natural killer cells versus B and T cells. Blood 97:2625-32
119. Yokota Y, Mansouri A, Mori S, Sugawara S, Adachi S, et al. 1999. Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397:702-6
120. Ikawa T, Fujimoto S, Kawamoto H, Katsura Y, Yokota Y. 2001. Commitment to natural killer cells requires the helix-loop-helix inhibitor Id2. Proc. Natl. Acad. Sci. USA 98:5164-69
121. Pan L, Sato S, Frederick JP, Sun XH, Zhuang Y. 1999. Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene. Mol. Cell. Biol. 19:5969-80
122. Rivera RR, Johns CP, Quan J, Johnson RS, Murre C. 2000. Thymocyte selection is regulated by the helix-loop-helix inhibitor protein, Id3. Immunity 12:17-26
123. Friedman AD. 2002. Transcriptional regulation of granulocyte and monocyte development. Oncogene 21:3377-90
124. DeKoter RP, Walsh JC, Singh H. 1998. PU.1 regulates both cytokine-dependent proliferation and differentiation of granulocyte/macrophage progenitors. EMBO J. 17:4456-68
125. Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG. 1997. Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein α-deficient mice. Proc. Natl. Acad. Sci. USA 94:569-74
126. Jones LC, Lin ML, Chen SS, Krug U, Hofmann WK, et al. 2002. Expression of C/EBPβ from the C/ebpα gene locus is sufficient for normal hematopoiesis in vivo. Blood 99:2032-36
127. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, et al. 1995. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80:353-61
128. Chen X, Liu W, Ambrosino C, Ruocco MR, Poli V, et al. 1997. Impaired generation of bone marrow B lymphocytes in mice deficient in C/EBPβ. Blood 90:156-64
129. Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH. 1996. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. USA 93:12355-58
130. Pevny L, Simon MC, Robertson E, Klein WH, Tsai SF, et al. 1991. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1. Nature 349:257-60
131. Takahashi S, Shimizu R, Suwabe N, Kuroha T, Yoh K, et al. 2000. GATA factor transgenes under GATA-1 locus control rescue germline GATA-1 mutant deficiencies. Blood 96:910-16
132. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. 1997. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16:3965-73
133. Tsang AP, Fujiwara Y, Horn DB, Orkin SH. 1998. Failure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOG. Genes Dev. 12:1176-88
134. Tsang AP, Visvader JE, Turner CA, Fujiwara Y, Yu C, et al. 1997. FOG, a multitype zinc finger protein, acts as a cofactor for transcription factor GATA-1 in erythroid and megakaryocytic differentiation. Cell 90:109-19
135. + T cells. J. Exp. Med. 194:1461-71
136. Snapper CM, Rosas FR, Zelazowski P, Moorman MA, Kehry MR, et al. 1996. B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J. Exp. Med. 184:1537-41
137. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, et al. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-40
138. + dendritic cells. Immunity 9:839-47
139. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, et al. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531-36
140. Hacker C, Kirsch RD, Ju XS, Hieronymus T, Gust TC, et al. 2003. Transcriptional profiling identifies Id2 function in dendritic cell development. Nat. Immunol. 4:380-86
141. Wu L, Nichogiannopoulou A, Shortman K, Georgopoulos K. 1997. Cell-autonomous defects in dendritic cell populations of Ikaros mutant mice point to a developmental relationship with the lymphoid lineage. Immunity 7:483-92
142. Graf T, McNagny K, Brady G, Frampton J. 1992. Chicken "erythroid" cells transformed by the Gag-Myb-Ets-encoding E26 leukemia virus are multipotent. Cell 70:201-13
143. Kulessa H, Frampton J, Graf T. 1995. GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts. Genes Dev. 9:1250-62
144. Nerlov C, Graf T. 1998. PU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors. Genes Dev. 12:2403-12
145. 141a. Rekhtman N, Radparvar F, Evans T, Skoultchi AI. 1999. Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells. Genes Dev. 13:1398-411
146. 141b. Nerlov C, Querfurth E, Kulessa H, Graf T. 2000. GATA-1 interacts with the myeloid PU.1 transcription factor and represses PU.1-dependent transcription. Blood 95:2543-51
147. 141c. Zhang P, Zhang X, Iwama A, Yu C, Smith KA, et al. 2000. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 96:2641-48
148. 141d. Stopka T, Amanatullah DF, Papetti M, Skoultchi AI. 2005. PU.1 inhibits the erythroid program by binding to GATA-1 on DNA and creating a repressive chromatin structure. EMBO J. 24:3712-23
149. Zhang P, Behre G, Pan J, Iwarna A, Wara-Aswapati N, et al. 1999. Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1. Proc. Natl. Acad. Sci. USA 96:8705-10
150. Okuno Y, Huang G, Rosenbauer F, Evans EK, Radomska HS, et al. 2005. Potential autoregulation of transcription factor PU.1 by an upstream regulatory element. Mol. Cell. Biol. 25:2832-45
151. Yu C, Cantor AB, Yang H, Browne C, Wells RA, et al. 2002. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med. 195:1387-95
152. Iwasaki H, Mizuno S, Wells RA, Cantor AB, Watanabe S, Akashi K. 2003. GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages. Immunity 19:451-62
153. Heyworth C, Pearson S, May G, Enver T. 2002. Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO J. 21:3770-81
154. Galloway JL, Wingert RA, Thisse C, Thisse B, Zon LI. 2005. Loss of Gata1 but not Gata2 converts erythropoiesis to myelopoiesis in zebrafish embryos. Dev. Cell 8:109-16
155. Rhodes J, Hagen A, Hsu K, Deng M, Liu TX, et al. 2005. Interplay of Pu.1 and Gata1 determines myelo-erythroid progenitor cell fate in zebrafish. Dev. Cell 8:97-108
156. Cantor AB, Orkin SH. 2001. Hematopoietic development: a balancing act. Curr. Opin. Genet. Dev. 11:513-19
157. Walsh JC, DeKoter RP, Lee HJ, Smith ED, Lancki DW, et al. 2002. Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. Immunity 17:665-76
158. Querfurth E, Schuster M, Kulessa H, Crispino JD, Doderlein G, et al. 2000. Antagonism between C/EBPβ and FOG in eosinophil lineage commitment of multipotent hematopoietic progenitors. Genes Dev. 14:2515-25
159. Welch JJ, Watts JA, Vakoc CR, Yao Y, Wang H, et al. 2004. Global regulation of erythroid gene expression by transcription factor GATA-1. Blood 104:3136-47
160. Kummalue T, Friedman AD. 2003. Cross-talk between regulators of myeloid development: C/EBPα binds and activates the promoter of the PU.1 gene. J. Leukoc. Biol. 74:464-70
161. Xie H, Ye M, Feng R, Graf T. 2004. Stepwise reprogramming of B cells into macrophages. Cell 117:663-76
162. Crispino JD, Lodish MB, MacKay JP, Orkin SH. 1999. Use of altered specificity mutants to probe a specific protein-protein interaction in differentiation: the GATA-1:FOG complex. Mol. Cell 3:219-28
163. Ness SA, Kowenz-Leutz E, Casini T, Graf T, Leutz A. 1993. Myb and NF-M: combinatorial activators of myeloid genes in heterologous cell types. Genes Dev. 7:749-59
164. McNagny K, Graf T. 2002. Making eosinophils through subtle shifts in transcription factor expression. J. Exp. Med. 195:F43-47
165. Wang X, Crispino JD, Letting DL, Nakazawa M, Poncz M, Blobel GA. 2002. Control of megakaryocyte-specific gene expression by GATA-1 and FOG-1: role of Ets transcription factors. EMBO J. 21:5225-34
166. Tenen DG, Hromas R, Licht JD, Zhang DE. 1997. Transcription factors, normal myeloid development, and leukemia. Blood 90:489-519
167. Lindeman GJ, Adams JM, Cory S, Harris AW. 1994. B-lymphoid to granulocytic switch during hematopoiesis in a transgenic mouse strain. Immunity 1:517-27
168. Klinken SP, Alexander WS, Adams JM. 1988. Hemopoietic lineage switch: v-raf oncogene converts Emu-myc transgenic B cells into macrophages. Cell 53:857-67
169. 161a. Heavey B, Charalambous C, Cobaleda C, Busslinger M. 2003. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPα and GATA factors. EMBO J. 22:3887-97
170. LefebvreJM, Haks MC, Carleton MO, Rhodes M, Sinnathamby G, et al. 2005. Enforced expression of Spi-B reverses T lineage commitment and blocks β-selection. J. Immunol. 174:6184-94
171. 162a. Dionne CJ, Tse KY, Weiss AH, Franco CB, Wiest DL, et al. 2005. Subversion of T lineage commitment by PU.1 in a clonal cell line system. Dev. Biol. 280:448-66
172. 162b. Hsu LY, Liang HE, Johnson K, Kang C, Schlissel MS. 2004. Pax5 activates immunoglobulin heavy chain V to DJ rearrangement in transgenic thymocytes. J. Exp. Med. 199:825-30
173. Rolink AG, Nutt SL, Melchers F, Busslinger M. 1999. Long-term in vivo reconstitution of T-cell development by Pax5-deficient B-cell progenitors. Nature 401:603-6
174. Horcher M, Souabni A, Busslinger M. 2001. Pax5/BSAP maintains the identity of B cells in late B lymphopoiesis. Immunity 14:779-90
175. Mikkola I, Heavey B, Horcher M, Busslinger M. 2002. Reversion of B cell commitment upon loss of Pax5 expression. Science 297:110-13
176. Nutt SL, Urbanek P, Rolink A, Busslinger M. 1997. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev. 11:476-91
177. Zhuang Y, Soriano P, Weintraub H. 1994. The helix-loop-helix gene E2A is required for B cell formation. Cell 79:875-84
178. Ikawa T, Kawamoto H, Wright LY, Murre C. 2004. Long-term cultured E2A-deficient hematopoietic progenitor cells are pluripotent. Immunity 20:349-60
179. 168a. Rosenbauer F, Owens BM, Yu L, Tumang JR, Steidl U, et al. 2006. Lymphoid cell growth and transformation are suppressed by a key regulatory element of the gene encoding PU.1. Nat. Genet. 38:27-37
180. Rosenbauer F, Wagner K, Kutok JL, Iwasaki H, Le Beau MM, et al. 2004. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 36:624-30
181. DeKoter RP, Singh H. 2000. Regulation of B lymphocyte and macrophage development by graded expression of PU.1. Science 288:1439-41
182. 170a. Godin I, Cumano A. 2002. The hare and the tortoise: an embryonic haematopoietic race. Nat. Rev. Immunol. 2:593-604
183. Hardy RR, Hayakawa K. 2001. B cell development pathways. Annu. Rev. Immunol. 19:595-621
184. MacDonald HR, Radtke F, Wilson A. 2001. T cell fate specification and αβ/γδ lineage commitment. Curr. Opin. Immunol. 13:219-24
185. Ceredig R, Rolink T. 2002. A positive look at double-negative thymocytes. Nat. Rev. Immunol. 2:888-97
186. Hu M, Krause D, Greaves M, Sharkis S, Dexter M, et al. 1997. Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev. 11:774-85
187. Miyamoto T, Iwasaki H, Reixis B, Ye M, Graf T, et al. 2002. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev. Cell 3:137-47
188. Ye M, Iwasaki H, Laiosa CV, Stadtfeld M, Xie H, et al. 2003. Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. Immunity 19:689-99
189. Delassus S, Titley I, Enver T. 1999. Functional and molecular analysis of hematopoietic progenitors derived from the aorta-gonad-mesonephros region of the mouse embryo. Blood 94:1495-503
190. Forsberg EC, Prohaska SS, Katzman S, Heffher GC, Stuart JM, Weissman IL. 2005. Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet. 1:e28
191. Gounari F, Aifantis I, Martin C, Fehling HJ, Hoeflinger S, et al. 2002. Tracing lymphopoiesis with the aid of a pTα-controlled reporter gene. Nat. Immunol. 3:489-96
192. Gilliland DG, Griffin JD. 2002. The roles of FLT3 in hematopoiesis and leukemia. Blood 100:1532-42
193. Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, et al. 2004. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306:269-71
194. He L, Hannon GJ. 2004. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5:522-31
195. Ambros V. 2004. The functions of animal microRNAs. Nature 431:350-55
196. Zhao Y, Samal E, Srivastava D. 2005. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436:214-20
197. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. 2005. MicroRNA expression profiles classify human cancers. Nature 435:834-38
198. Chen CZ, Li L, Lodish HF, Bartel DP. 2004. MicroRNAs modulate hematopoietic lineage differentiation. Science 303:83-86
199. Muller C, Leutz A. 2001. Chromatin remodeling in development and differentiation. Curr. Opin. Genet. Dev. 11:167-74
200. Johnson K, Pflugh DL, Yu D, Hesslein DG, Lin KI, et al. 2004. B cell-specific loss of histone 3 lysine 9 methylation in the V(H) locus depends on Pax5. Nat. Immunol. 5:853-61
201. Marecki S, McCarthy KM, Nikolajczyk BS. 2004. PU.1 as a chromatin accessibility factor for immunoglobulin genes. Mol. Immunol. 40:723-31
202. Lutterbach B, Westendorf JJ, Linggi B, Isaac S, Seto E, Hiebert SW. 2000. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J. Biol. Chem. 275:651-56
203. Lee GR, Fields PE, Flavell RA. 2001. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity 14:447-59
204. Muller C, Calkhoven CF, Sha X, Leutz A. 2004. The CCAAT enhancer-binding protein α(C/EBPα) requires a SWI/SNF complex for proliferation arrest. J. Biol. Chem. 279:7353-58
205. Tagoh H, Schebesta A, Lefevre P, Wilson N, Hume D, et al. 2004. Epigenetic silencing of the c-fins locus during B-lymphopoiesis occurs in discrete steps and is reversible. EMBO J. 23:4275-85
206. Akashi K, He X, Chen J, Iwasaki H, Niu C, et al. 2003. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 101:383-89